Rock Springs Capital Management LP Q1 2024 Filing

Filed May 15, 2024

Portfolio Value

$3.9B

Holdings

113

Report Date

Q1 2024

Filing Type

13F-HR

All Holdings (113 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	AMLXAMYLYX PHARMACEUTICALS INC	1,011,412	$2.9M	0.07%
102	TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC	3,250,000	$2.8M	0.07%
103	BMEABIOMEA FUSION INC	181,147	$2.7M	0.07%
104	NVV1NOVAVAX INC	537,625	$2.6M	0.07%
105	CYPHLEAP THERAPEUTICS INC	911,937	$2.4M	0.06%
106	SPRBSPRUCE BIOSCIENCES INC	2,609,125	$2.1M	0.05%
107	NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC	1,000,000	$1.8M	0.05%
108	VIGLVIGIL NEUROSCIENCE INC	471,958	$1.6M	0.04%
109	XLOXILIO THERAPEUTICS INC	1,440,759	$1.6M	0.04%
110	OKURRENEO PHARMACEUTICALS INC	751,730	$1.2M	0.03%
111	NVRO 2.75 04/01/25NEVRO CORP	500,000	$474K	0.01%
112	TLPHTALPHERA INC	316,460	$326K	0.01%
113	NUVB/WSNUVATION BIO INC	134,028	$41K	0.00%

PreviousPage 2 of 2